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Abstract
Since 1995, the Government has encouraged people to establish  Centre of Development and Implementation 
of Traditional Medicine or Sentra Pengembangan dan Penerapan Pengobatan Tradisional (SP3T) through the 
Ministry of Health’s decree  No. 0584/Menkes/SK/VI/1995. At the moment several centers have been realized 
and provided herbal medicine (HM) in their service. The aim of the survey was to get the picture of the perception 
and the usage of HM by medical doctors. Questionnaires were distributed by online system to 267 doctors. The 
results showed that 53% respondents were 41-55 years old, whereas 47% were 40 or younger, more than half (59%) 
were  female. With regards to their medical specializations 29% were GPs, 18%, internists, 6% neurologists and 
obstetricians, and 41% other specializations. Sixty five percent respondents did not prescribe HM but 35% prescribed 
occasionally. Those  who are not practicing or prescribing HM to their patients stated that they never learnt it (41%), 
were doubtful to its efficacy (41%), knew nothing about HM (29%), and were concern about the quality (18%). 
Although HM is relatively cheaper than modern medicine (59%), but 82% respondents stated that information on 
HM is lacking. They proposed that awareness about HM should be increased through seminars (88%), courses/
workshops (53%), journal publication (63%), brochures and leaflets (24%), and medical representative (18%). The 
use of HM by respondents is mainly for non-specific diarrhea (63%), hypertension and rheumatoid arthritis (38%), 
hypercholesterolemia (25%) and diabetes mellitus (13%). Respondents agreed that HM should be taught in medical 
schools  (94%)  for at least one semester (60%)  or two semesters (40%).
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Persepsi dan Penggunaan Obat Herba oleh Dokter 
Abstrak
Sesuai dengan Keputusan Menteri Kesehatan No. 0584/Menkes/SK/VI/1995, sejak 1995 Pemerintah telah 
menganjurkan masyarakat untuk membentuk Sentra Pengembangan dan Penerapan Pengobatan Tradisional 
(SP3T). Saat ini sudah ada beberapa pusat pelayanan pengobatan herba. Tujuan survei ini untuk mendapatkan 
gambaran tentang persepsi dan penggunaan obat herba (OH) oleh para dokter. Kuesioner disebarkan secara daring 
kepada 267 alumni dan non-alumni Fakultas Kedokteran  UKI. Hasilnya memperlihatkan 53% responden berusia 
41-55 tahun, 47% berusia sampai 40 tahun, serta 59% terdiri atas perempuan. Dari segi spesialisasi didapatkan 
29% dokter umum, 18% spesialis penyakit dalam, 6% spesialis penyakit syaraf dan ahli kandungan sedangkan 41% 
memiliki spesialisasi lain. Enam puluh lima persen responden tidak meresepkan OH dan hanya 35% responden yang 
meresepkan secara tidak rutin. Hal itu karena mereka tidak pernah belajar OH (41%), tidak yakin akan efikasinya 
(41%), tidak tahu sama sekali tentang OH (29%) dan tidak yakin akan mutunya (18%). Meskipun OH relatif lebih 
murah daripada obat konvensional (59%) tapi 82% responden menyatakan informasi tentang OH sangat kurang. 
Mereka mengusulkan agar informasi OH ditingkatkan melalui seminar (88%), kursus/lokakarya (53%), publikasi 
lewat jurnal (63%), brosur dan liflet (24%) dan medical representative (18%). Penggunaan OH oleh responden 
terutama untuk diare non-spesifik (63%), hipertensi dan artritis reumatoid (38%), hiperkolesterolemia (25%) dan 
diabetes mellitus (13%). Responden setuju agar OH diajarkan di fakultas kedokteran (94%) sekurang-kurangnya 
satu semester (60%) atau dua semester (40%). 
Kata kunci: fitofarmaka, pendidikan kedokteran, persepsi, obat herba
The paper was  presented partially at the International Symposium & Seminar - Use of Herbs for Prevention  of 
Vascular & Neurodegenerative Diseases, 8-9 March 2013 Faculty of Medicine,  Brawijaya University, Malang.
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Introduction
The use of herbal medicine (HM) 
is globally expanding. Once known as a 
product of local knowledge and use locally 
by indigenous people, the usage of HM 
becomes world-wide.1 Up to now medical 
practice and public health services in 
countries, such as Germany, China, East 
Asia, India, Far East and South East Asia, 
countries, are also offering alternative 
or herbal medicine to their patients.2-4 As 
a consequence, the need of evidence on 
efficacy and safety is certainly high as is 
directed by the World Health Organization 
(WHO) guidelines on herbal medicine.5, 
6 Although the use and acceptance of HM 
by patients and public have been increasing, 
there is a great portion of medical doctors 
who refuse to use or ignore the usage of 
HM. A survey in Queensland, Australia, 
found that general practitioners (GPs) lack 
knowledge and require information on 
complementary medicine, although most 
of them use complementary medicine, 
including HM for their patients either by 
self-medication or in-addition to their 
concurrent use of conventional medicine.7
Jamu, a specific name for Indonesia’s 
HM and like any other HMs, has its own 
tradition and used within certain cultures 
in Indonesia. The Ministry of Health’s 
decree, released in 1995, encouraged  every 
particular health center in Indonesia to 
establish the Centre of Development and 
Implementation of Traditional Medicine 
or Sentra Pengembangan dan Penerapan 
Pengobatan Tradisional (SP3T).8 In order 
to enhance clinical research on HM, and to 
increase the “body of knowledge” on  HM, in 
2010, again the Ministry of Health initiated 
clinical-based research on jamu through 
Permenkes No. 003/Menkes/Per/I/2010.9 
The first center  “Hortus Medicus”, was 
established in Tawangmangu, Central 
Java, which formerly known as the center 
for cultivating medicinal plants. Under 
this decree, however, the center receives 
patients and offers them herbal medicine. 
In the center, every case has been carefully 
recorded as a pre- and post-intervention 
treatment. This initiative will hopefully 
establish a strong and large clinical evidence 
of the efficacy of jamu for certain ailments.
To date, there is no published study 
on perception and usage of HM by the 
Indonesian medical doctors. We only found 
one study that revealed the perception and 
knowledge of risk of jamu among the urban 
consumers.10 Therefore, the aim of the study 
was to evaluate the perception and usage of 
HM by medical doctors in Indonesia.
Method
An online questionnaire was developed 
and distributed to 267 medical doctors 
graduated from the medical school of 
Universitas Kristen Indonesia (UKI). 
There were 17 items  in the questionnaire 
comprised of demographic characteristics, 
perceptions and usage pattern of herbal 
medicine by the respondents. The responses 
were automatically tallied and summarized 
by the online system of the computer that 
equipped with Google’s database software. 
The collected data are descriptively 
presented.
Results
The response rate of the survey was 72% 
(192/267), which comprised of 111 (58%) 
male and 81 (42%) female. The general 
demographic of respondents is presented in 
Table 1. 
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Figure 1. Distribution of respondents’ reasons of not using HM
Twenty-five percent of respondents  who 
use and prescribe HM in their daily practice 
admitted that  they  use reference from 
their colleagues who also use HM in their 
practice; 25% of respondents use empirical 
data of HM; and 50% of respondents rely 
on scientific data such as toxicology and 
clinical trials found in journals.
Table 1. Characteristics of Respondents and the Pattern of HM Usage 
Characteristics Use of herbal medicine
Never Sometimes Often
Age (years) n (%) n % n % n %
<30 33 (17) 10 5.2 21 10.9 2 1
31-40 48 (25) 15 7.8 29 15.1 4 2
41-55 103 (54) 80 41.6 22 11.4 1 0.5
>55 8 (4) 6 3.1 1 0.5 1 0.5
192 (100) 111 57.7 73 37.9 8 4
Medical 
specialization
General practitioner 55 (29) 45 23.4 8 4.1 2 1
Internist 48 (25) 44 23.4 4 2 0 0
Obstetric-gynecologist 8 (4) 8 3.6 0 0 0 0
Neurologist 8 (4) 8 3.6 0 0 0 0
Others 72 (38) 51 26.5 18 9.3 3 2
192 (100) 156 81.3 30 15.7 5 3
Practice site Hospital 81 (42) 78 40.6 2 1 1 0.5
Private 88 (46) 70 36.4 10 5.5 8 4.1
Polyclinic 23 (4) 20 10.4 1 0.5 2 1
192 (100) 168 87.4 13 7.0 11 5.6
Practice years < 5 years 63 (33) 45 23.4 15 7.8 3 1.5
6-10 years 48 (25) 26 13.5 18 9.4 4 2.1
10-20 years 73 (38) 50 26.4 18 9.4 5 2.6
>20 years 8 (4) 6 3.1 1 0.5 1 0.5
192 (100) 127 66.1 52 27.1 13 6.8
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Figure 2. The quality and comprehensive information on HM
Concerning the information on HM that is 
needed for health care providers in deciding 
their options to prescribe or not prescribe is 
depicted in Figure 2, whilst Figure 3 shows 
the suggestions from the responders on the 
strategies to be implemented in spreading 
the information on HM among the medical 
doctors.
Figure 3. Suggested strategies to increase awareness and spread of information on HM to
                                 medical doctors
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Discussion 
The increasing trend of herbal 
medicine usage in the last 20 years by 
most of the people through self-medication 
is inevitable; however most of the care 
giver especially medical doctors are still 
reluctant to use HM in their daily practices. 
Consistent with other study11, in accordance 
to the age, 58% of our respondents are not 
practicing or prescribing any HM to their 
patients (Table. 1) and this is due to lack 
of competency on HM (38%), doubtful to 
its efficacy (38%) or their concern on the 
quality or product standardization practices 
of HM. As depicted in Figure 1, there are 
two highest main reasons that respondents 
reluctant to use or prescribe HM, namely, 
their basic knowledge about HM and lack 
of efficacy. A survey done in the United 
Kingdom also revealed that knowledge and 
understanding were also low (very poor: 
10.4%; quite poor: 36.2%, respectively). 
Around 75% respondents answered that 
in some circumstances HM did help and 
22.2% of them even did not believe in 
HM.12 In order to increase comprehensive 
information on HM’s efficacy and safety to 
medical doctors, our study showed (Figure 
3) that seminars and symposiums second to 
publication in peer-reviewed journals would 
be an effective strategies.
It is shown in some studies, although the 
use of HM in general practice and in public 
are increased, knowledge and information 
on HM were insufficient either in teaching 
hospital or in school of pharmacies.2,4,13,14 
These facts are in accordance to our results 
(Figure 2). Furthermore, a comprehensive 
literature and learning methods on HM in 
Indonesia are not yet available. In some 
countries pharmacopeia of HM are available 
not only to health personnel but also to public. 
Information about HM is made obviously 
even easier through web-based database that 
is accessible to the people.12,15,16
One important issue that was brought by 
respondents is evidence of clinical efficacy 
of HM which should be made through 
rigorous (controlled and randomized) 
clinical trial.1,17,18 Traditional chinese 
medicine (TCM) and Indian traditional 
medicine, particularly, have been studied 
according to the Consolidated Standards of 
Reporting Trials (CONSORT) approach, but 
clinical trial of Indonesian HM is still rare 
or the studies are still focus on pre-clinical 
trials.16,17,19 Recently, Rochsismandoko et 
al20 published their clinical trial results 
of propolis, a resin collected by bee from 
various plants, which contain among others 
flavonoids, phenolic acids, vitamins, amino 
acids on patients with dengue hemorrhagic 
fever (DHF).  It showed that propolis could 
shorten the length-of-stay (LOS) of the 
patients. This study, thought to be the first 
clinical trial of its kind in Indonesia, was 
conducted in single-blinded randomized-
controlled trial mode, with only 20 patients. 
To increase the level of the clinical evidence, 
further study with more numbers of patients 
should be done.
Early exposure of knowledge and 
practice of HM to medical students are 
important so many doctors will prescribe 
HM to their patients in the future. As it is 
acknowledged by the respondents in this 
study that most of conventional medical 
schools, except in some medical schools in 
China,  have not accepted or adopted the 
complementary and alternative medicine 
(CAM), including herbal medicine, into 
their curricula. If CAM is to be included in 
the curriculum, issues related to the origin 
of culture, beliefs and practices within the 
particular society, like Ayurveda mostly 
practiced in India, and TCM in China 
should be put into consideration. Medical 
schools in Indonesia, for example, can not 
directly place Ayurveda or TCM or others 
from various cultures into the curricula. 
Some of the Indonesian traditional 
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medicine, unfortunately, is not well written 
or documented as a complete system of 
knowledge and practice of health like the 
conventional medicine.17 Therefore, we 
have to gather and collect amount of data 
of ethno botany and ethno pharmacology 
from various parts of Indonesia and start 
to establish a comprehensive knowledge of 
traditional health system.
Conclusions
The findings of this survey indicate 
that despite the endorsement of Indonesian 
government to health providers to use HM in 
their daily practice, medical doctors are still 
reluctant to prescribe HM for their patients 
due to lack of comprehensive information 
on efficacy, safety and quality. More clinical 
evidences, which can be gathered from 
properly designed clinical trials, are still 
needed. Intensive dissemination through 
publications in peer-reviewed journals, 
seminars, workshops and courses could also 
enhance the knowledge of medical doctors 
on HM. Moreover, HM could be introduced 
and taught to medical students which could 
enhance the perception and use of HM by 
medical doctors.
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